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Abstract: One-dimensional nanostructures, such as silver nanowires (AgNWs), have attracted
considerable attention owing to their outstanding electrical, thermal and antimicrobial properties.
However, their application in the prevention of infections linked to bone tissue regeneration
intervention has not yet been explored. Here we report on the development of an innovative
scaffold prepared from chitosan, composite hydroxyapatite and AgNWs (CS-HACS-AgNWs) having
both bioactive and antibacterial properties. In vitro results highlighted the antibacterial potential of
AgNWs against both gram-positive and gram-negative bacteria. The CS-HACS-AgNWs composite
scaffold demonstrated suitable Ca/P deposition, improved gel strength, reduced gelation time,
and sustained Ag+ release within therapeutic concentrations. Antibacterial studies showed that
the composite formulation was capable of inhibiting bacterial growth in suspension, and able to
completely prevent biofilm formation on the scaffold in the presence of resistant strains. The hydrogels
were also shown to be biocompatible, allowing cell proliferation. In summary, the developed
CS-HACS-AgNWs composite hydrogels demonstrated significant potential as a scaffold material
to be employed in bone regenerative medicine, as they present enhanced mechanical strength
combined with the ability to allow calcium salts deposition, while efficiently decreasing the risk of
infections. The results presented justify further investigations into the potential clinical applications
of these materials.
Keywords: chitosan hydrogels; silver nanowires; controlled release; antimicrobial activity;
bone regeneration
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1. Introduction
Over the last few decades, significant advancements in the synthesis and characterization of
one dimensional (1D) nanostructured materials have led to novel applications in various fields
such as material science, energy technologies, engineering and biomedical science. A wide range
of nanostructures, such as nano-tubes, nano-fibres, nano-filaments, nano-whiskers, nano-horns,
nano-needles, nano-ribbons and nano-wires are classified as 1D nanostructures [1] that are all
characterized by a high aspect ratio [2]. These structures present remarkable variation in their electrical,
optical and magnetic properties when compared to the bulk materials due to their reduced dimensions,
controlled structure and large surface-to-volume ratio [3].
One, two, and three-dimensional silver nanostructures have been previously reported, with many
studies focusing on silver nanowires (AgNWs). AgNWs are anisotropically grown to obtain an
aspect ratio higher than 10 and are typically 10 nm–200 nm in diameter and 5 µm–100 µm in length [2].
To date, silver nanoparticles (AgNPs) have been much more extensively studied than AgNWs, and their
distinctive high thermal and electrical conductivity, surface-enhanced Raman scattering, chemical
stability, catalytic activity and non-linear optical behavior have been highlighted; as well as their
antibacterial activity that has extended their usage into several biomedical fields [4]. They are promising
agents against a wide range of fungi, viruses and bacterial species. Even though the mechanism of
action is still not entirely understood, it is believed that nanosilver serves as a source for Ag+ ions
that can rupture microbial cell walls, denature proteins, block cell respiration and eventually induce
cell death [5]. AgNPs have been used as antimicrobial agents in wound dressing [6], the coating of
catheters [7] and cardiovascular implants [8], bone cements [9] and dental materials [10]. Currently,
literature on the biomedical applications of AgNWs is still limited [2]. Emerging applications include
textiles [11], wound coatings [12], drug release and tissue regeneration [13].
While the antimicrobial activity of AgNWs in poly(vinylpyrrolidone) fibres has been just recently
reported [14], a few more biomedical applications of AgNWs are also being considered [2]. In this
paper we explore for the first time the potential use of AgNWs in composite materials designed
to prevent infection in bone regeneration applications, as they can provide advantages such as
biocompatibility, bioactivity and a 3D structure that can be employed as a supporting scaffold.
Bone defects remain a major problem in orthopedics and due to the deficiencies of current commercially
available bone grafts, alternative materials are needed [15]. Hydrogels are very good candidates to
overcome these obstacles since they are 3D, hydrophilic, crosslinked polymeric networks that resemble
the extracellular matrix with a porosity and aqueous environment that allow the transportation
of substances such as nutrients. The main challenge within the field is to produce a bioactive and
non-toxic hydrogel scaffold with sufficient mechanical strength [16,17]. Chitosan (CS), a polysaccharide
that is biocompatible, biodegradable and possesses antibacterial properties has been employed to
formulate such scaffolds, however, it has poor mechanical properties and inferior bone induction
capability [17]. Our previous work has focused on the development of reinforced bioactive CS scaffolds
containing hydroxyapatite (HA), which favors biomineralization of the scaffold, and carbon nanotubes
that provide mechanical enhancement [18]. The present work aims at substituting carbon nanotubes
with other 1D nanostructures, namely AgNWs, that afford the two-fold advantage of mechanically
reinforcing the hydrogel structure while enhancing its antibacterial properties. In fact, the success
of bone-defect surgical treatment can often be compromised by bacterial infection that may result in
chronic inflammation, implant failure and even death [19,20]. To date, few studies have been carried
out to evaluate the antibacterial properties of AgNWs alone [2], and very limited work has been done
in the investigation of their activity within composite materials. Here, we present the synthesis via
the polyol method and the full characterization of AgNWs, followed by the in vitro characterization
of the composite hydrogels containing the nanowires with particular emphasis on the antimicrobial,
bioactive and biocompatible properties of the scaffolds.
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2. Materials and Methods
Di-potassium hydrogen phosphate anhydrous and OCT cryostat embedding medium (Tissue
Tek®) were obtained from BDH (VWR, Lutterworth, UK). Glutamax and BCA Protein Assay Reagent
Kit were obtained from Thermo Fisher (Basingstoke, UK). An Alkaline Phosphatase Assay kit was
purchased from Abcam (Cambridge, UK). An ATPlite Luminescence ATP Detection Assay System was
purchased from PerkinElmer (Coventry, UK). The osteoblastic cell line MC3T3-E1 was purchased from
DSMZ (Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH,
Braunschweig, Germany). The Alpha-minimal essential medium (α-MEM) was purchased from Life
Technologies (Baltimore, MD, USA). Poly(vinylpyrrolidone) powder (PVP, 55 kDa), chitosan from
shrimp shells low viscosity (Mn 149.9 ± 4.7 kDa, Mw 170.5 ± 4.9 kDa as determined by GPC-MALLS;
degree of deacetylation ~85%, calculated by 1H-NMR) were sourced from Sigma-Aldrich (Irvine, UK).
All the other materials, unless specified above, were from Sigma-Aldrich (Irvine, UK) and Fisher
(Loughborough, UK).
2.1. Synthesis and Physicochemical Characterisation of Silver Nanowires (AgNWs)
AgNWs were synthesized via the polyol method, using silver nitrate (AgNO3) as the Ag
source [21]. PVP (3 g) was fully dissolved in glycerol (95 mL) by heating to 80 ◦C. The solution
was cooled down and AgNO3 (0.79 g) was added under vigorous stirring (800 rpm) until the powder
was fully dissolved. NaCl (5 mM in final solution) was mixed into 10 mL of glycerol and added to
the PVP/glycerol solution. The reaction temperature of the mixture was gradually raised to 210 ◦C.
Once the temperature was reached, it was maintained for a further 10 min. Samples (1 mL) were
taken at different temperatures, diluted (1:1) with water and analyzed by UV (300–900 nm, Thermo
Scientific Nicolet Evolution 100 UV-Visible Spectrophotometer, Thermo Fisher Scientific, Rochford, UK)
to follow the formation of the AgNWs. Finally, the reaction was cooled down to room temperature,
diluted 1:1 with deionized water and centrifuged (4000 rpm, 1 h), the pellet was washed twice with
isopropanol (4000 rpm, 30 min) and twice with deionized water (4000 rpm, 10 min). The product
was stored in deoxygenated purified water at room temperature, protected from light or freeze dried.
Freeze dried AgNWs were suspended in a chitosan solution (1%, in lactic acid 0.1 M) to achieve
different concentrations (0.5–1 mg/mL), by vortexing and sonicating for several minutes. These were
spread onto SEM specimen stubs and dried for two days under vacuum. Samples were gold-coated
with a Polaron e500 (Quoram Technologies, Lewes, UK) sputter coater and analyzed with a Jeol
JSM-6160L scanning electron microscope (Jeol, Welwyn Garden City, UK) with electron backscatter.
Images were analyzed with ImageJ (NIH, Madison, WI, USA) to determine the size distribution
of the wires obtained. Each individual AgNW identified in the pictures was measured 3 times.
Freeze-dried products were suspended in a chitosan solution (1%, in lactic acid 0.1 M), to achieve
different concentrations (0.5–1.5 mg/mL), by vortexing and sonicating for several min. Samples were
then dropped onto TEM grids (Agar scientific square mesh TEM support grids-copper) and allowed to
dry at room temperature and normal pressure. Dried grids were stored in Petri dishes in a desiccator
until observation using a Jeol JEM 2100 Transmission Electron Microscope (Jeol, Welwyn Garden
City, UK). The crystal structure of AgNWs was determined with a Bruker D2-Phaser diffractometer
(Bruker, Milan, IT). Instrumental parameters were: CuKα radiation, 30 kV, 10 mA, LynxEye PSD
detector with an angular opening of 5◦, 2θ range 6–84◦, step size 0.020◦, time per step 2 s, spinner 15
rpm. The alignment of the instrument was calibrated using an international standard (NIST 1976b).
A low-background silicon crystal specimen holder (Bruker) was used. The analysis was performed
at room temperature (25 ◦C). The XRD pattern was evaluated using the software Bruker EVA 14.2
(DIFFRACplus Package, Bruker, Milan, IT) coupled with the database PDF-2 (ICDD). Surface zeta
potential was measured using a Malvern Zetasizer instrument (Nano ZS, UK) using nanoparticles
suspended by sonication in deionized water. An average of twelve measurements per sample were
carried out.
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2.2. Formulation and Characterization of Hydrogels
Chitosan based hydrogels were formulated according to the composition listed in Table 1,
following the method previously described by Cancian et al. [18]. The full physicochemical
characterization of HACS has been previously reported [17]. The freeze dried scaffolds were stored
in a desiccator until further use. Gelation time was assessed using the inversion test, as described by
Ganji et al. [22]. Formulations were prepared in 2 mL aliquots; after the addition of GP, the composites
were vortexed (2 min) and stored at 4 ◦C for 12 h to remove air bubbles. The vials were then incubated
at 37 ◦C in a temperature controlled bath (Grant, SUB Aqua Pro, Shepreth, UK). The sol-gel transition
was determined by inverting the vials; the time at which the gel stopped flowing was recorded as the
gelation time.
Table 1. Components used in the formulation of each millilitre of hydrogel. CS: chitosan; HACS:
hydroxyapatite chitosan composite; AgNWs: silver nanowires; GP: glycerol phosphate.
Component CS CS-HACS CS-HACS-AgNWs CS-AgNWs
Lactic acid (0.1 M) 0.9 mL 0.9 mL 0.9 mL 0.9 mL
Chitosan 20 mg 20 mg 20 mg 20 mg
HACS – 8.6 mg 8.6 mg –
AgNWs (powder) – – 4 mg 4 mg
GP (1.12 g/mL) 0.1 mL 0.1 mL 0.1 mL 0.1 mL
Texture profile analysis was performed using a texture analyzer (XT plus, Stable Micro Systems
Ltd., Godalming, UK) by driving a Delrin (polyformaldehide) probe (10 mm diameter) into the gels at
1 mm/s and to a depth of 5 mm; six measurements were taken at room temperature before and after
the sol/gel transition took place. Force/distance curves were obtained and the maximum force value
recorded was reported as gel strength (N).
An equilibrium of swelling was determined on freeze-dried hydrogels that were weighed and
allowed to swell in phosphate buffer solution (PBS, 15 mL, pH = 7.4) at 37 ◦C. At different time
points, the hydrogels were removed from the buffer and weighed, after removing excess liquid.
The experiment (carried out in triplicate) was continued until equilibrium was reached. The swelling





where Ws and Wd represent the weight of the swollen and dry state samples, respectively.
The porosity of the scaffolds was determined on dried gels according to the method described
by Nanda et al. [23]. The in vitro degradation of pre-weighed dried scaffolds was carried out in 5 mL
sterile phosphate-buffered solution (PBS, pH 7.4) containing 1.0 mg/mL lysozyme. The PBS/lysozyme
solution was changed every 3–4 days. Samples were incubated at 37 ◦C with gentle mechanical
agitation for the period of study (80 rpm). After 7, 14 and 21 days, samples were removed from the
medium, rinsed with distilled water, freeze dried and weighed. The experiment was carried out in
triplicate. The extent of in vitro degradation was calculated using Equation (2):
Mass loss(%) = [(Wi −Wd)/Wi]× 100 (2)
where Wi is the initial weight of the scaffold and Wd is the weight of the scaffold after the
degradation experiment.
In vitro calcification studies were performed to investigate the ability of the composite hydrogels
to induce calcium salts deposition. The freeze dried samples were submerged into 15 mL of simulated
body fluid (SBF, prepared according to Kokubo and Takadama [24]) and incubated at 37 ◦C for 7,
14 and 21 days; the SBF was changed every four days. Finally, samples were freeze dried. Controls
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were hydrated in deionized water for 5 h and dried as above. All samples were analyzed by SEM (as
described above), coupled with EDS (Silicon Drift Detector (SDD)—X-MaxN, Oxford Instruments, UK).
EDS images for calcium (Ca) and phosphorus (P) were analyzed using ImageJ 3D Viewer after being
overlaid to corresponding SEM images. The total area of overlapping for Ca and P onto the total sample
surface area was used to calculate percentage of Ca and P salt deposition (n = 3). In order to further
explore the overall salt deposition within the scaffolds micro-CT was used. Non coated scaffolds were
scanned with the microCT scanner (Versa 510, Zeiss, Dublin, CA, USA) set to a voltage of 40 kV and a
current of 76 µA. An isotropic voxel size of 4.077 µm and exposure of 3 s were used. The images were
then analyzed using ImageJ (v1.50, NIH, Madison, WI, USA) as described by Cancian et al. [18].
2.3. Ag+ Release Studies
Dried AgNWs and freeze-dried hydrogels were soaked in HPLC-grade water and incubated at
37 ◦C, with shaking (90 rpm). At scheduled time points, the AgNWs in water were centrifuged at
2000 rpm for 3 min (this step was not required for CS-HACS-AgNWs) and 1 mL of supernatant was
taken and replaced with 1 mL of fresh water. The concentration of silver ions was determined by a
furnace atomic absorption spectro-photometer (Varian SpectrAA 220FS, Varian Medical Systems,
Crawley, UK) at a wavelength and spectral bandwidth of 328.1 nm and 0.2 nm, respectively.
The experiment was carried out in triplicate.
2.4. Antimicrobial Activity of AgNWs
The antibacterial activity of AgNWs was examined by a suspension assay against
gram-negative Escherichia coli (ATCC 25922) and gram-positive Staphylococcus aureus (ATCC 25923),
Methicillin-resistant Staphylococcus aureus (ATCC 12403) and Staphylococcus saprophyticus (ATCC 15305).
The bacteria were transferred from −80 ◦C (15% glycerol) into 5 mL of fresh sterile LB medium by a
sterile toothpick and incubated (at 37 ◦C and 200 rpm) until the bacterial suspension was cloudy (one
day for E. coli and S. aureus, two days for MRSA and three days for S. saprophyticus). Then, 50 µl of
bacterial suspension was transferred into 5 mL of fresh sterile LB medium and the bacteria were further
incubated at 37 ◦C until the suspension was newly cloudy (one day for E. coli, S. aureus and MRSA
and two days for S. saprophyticus). Cells at a concentration of 1 × 106 CFU/mL (equal to an OD600nm
of 0.001, MaxQ™ 8000, Thermo Scientific) were grown in 50 mL of liquid LB medium supplemented
with 12.5, 25, 50 and 100 µg/mL of AgNWs. The stock suspensions of AgNWs were prepared the day
before use and stored at 4 ◦C. This was accomplished by firstly weighing the dried AgNWs and finally
resuspending them in sterile LB by sonication (40 kHz, CamLab, Cambridge, UK) until the suspension
was homogeneous. This step ensured the sterilization of the AgNWs suspension due to high frequency
ultrasounds. Pure medium with bacterial cell inoculation and pure LB served as controls. Growth
rates and bacterial concentrations were detected by measuring the optical density of the inoculated LB
broth medium at 600 nm at different time points. Different concentrations (12.5, 25, 50 and 100 µg/mL)
of the stock AgNWs suspension and pure LB were used as blanks. The experiment was carried out
into autoclaved 250 mL glass flasks at 37 ◦C and 200 rpm, in triplicate.
2.5. Antimicrobial Activity of Composite Hydrogels
The antibacterial activity of CS-HACS and CS-HACS-AgNWs scaffolds was examined by a
suspension assay against the micro-organisms listed in Section 2.4. The scaffolds were sterilized by
firstly submerging them in 70% (v/v) ethanol for 15 min and then rinsing them three times with sterile
PBS. Finally, they were autoclaved in LB and sonicated for 15 min at 40 kHz before discarding the LB.
All the scaffolds were then placed into 2 mL of 1 × 105 CFU/mL cell suspension in glass vials and
analyzed as described below.
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2.5.1. Biofilm Formation Assay
For the determination of biofilm formation, after incubation at 37 ◦C and 100 rpm for 24 h,
the hydrogels were gently soaked in PBS for 10 s to remove loosely adherent bacteria and subsequently
fixed in paraformaldehyde (4% in PBS) overnight, before being washed in PBS (3 times) and soaked
into 5%, 10%, 20% (2 h) and 30% (overnight) sucrose solutions. The scaffolds were transferred into
aluminum cases and embedded into optimal cutting temperature compound (OCT). Then, they were
rapidly frozen in pentane, submerged into liquid nitrogen. Hydrogels were stored at −80 ◦C until
cryosectioning. Hydrogels were cut into 7–9 µm slices that were placed onto poly-L-lysine coated slides.
The sections were air-dried for 30 min and stored at−20 ◦C until staining. Prior to staining, the sections
were washed with deionized water for 1 h and stained with carbol fuchsin (for gram-negative cells) or
crystal violet (for gram-positive cells). Slides were stained for 1 min and then washed with running
deionized water for 5 min. The slides were left to dry and observed with an optical microscope
(GXM-L1500BHTG, GTVision, Sudbury UK).
2.5.2. Antimicrobial Testing of the Dried Hydrogels
To test the antimicrobial properties of the scaffolds, these were prepared as above but samples of
the incubation medium were taken at scheduled times (3, 7 and 24 h), the bacterial suspensions were
transferred into a sterile 15 mL tube and the scaffolds were washed with sterile PBS (1 mL) vortexing
for 30 s. The last step was done for collecting the not fully attached bacteria. The PBS solution was
then transferred into the 15 mL tube. The total collected bacterial solution was serially diluted in PBS
(from 10−1 to 10−15) into sterile 2 mL test tubes and plated in triplicate on LB agar plates (100 µL per
plate). After static incubation for 18 h at 37 ◦C (HeraTherm Incubator, Thermo Scientific) the colony
forming units (CFUs) were manually counted. Controls were prepared with: LB only, scaffolds and LB,
and individual bacteria in LB only.
2.6. Cell Culture Studies
The osteoblastic cell line MC3T3-E1 was cultured with proliferation medium composed of
α-MEM containing 10% fetal bovine serum and 1% penicillin/streptomycin. Cells were grown
at 37 ◦C in a humid atmosphere with 5% CO2. The medium was refreshed three times a week.
Freeze-dried hydrogels were hydrated for 5 min, then immersed in 70% ethanol, washed with
phosphate buffer saline (PBS) four times, transferred into a 24-well plate, and irradiated with UVA
light overnight. Samples were equilibrated in proliferation medium for 1 h, the medium was then
removed and 1.8 × 104 cells were seeded in each well in osteogenic differentiation medium which
contained α-MEM without nucleosides, 10% FBS, 1% penicillin/streptomycin, 1% glutamax, 10 nM
β-glycerophosphate and 50 µg/mL ascorbic acid. Cultures grown on tissue-culture polystyrene plates
were used as control. After 7 and 14 days from seeding, cell proliferation, and differentiation were
evaluated. Cell viability was assessed using the Luminescence ATP Detection Assay according to the
manufacturer’s instructions. Briefly, substrate solution was added to cell lysates and the luminescence
was measured with VICTOR3 1420 Multilabel Counter (PerkinElmer, Coventry, UK). Counts per
seconds were converted in cell number by using a standard curve previously obtained with known cell
numbers (from 104 to 105 cells). The detection of ALP activity was carried out by using the Alkaline
Phosphatase Assay kit, following the manufacturer’s instructions. Briefly, cell lysates were centrifuged
and supernatants were treated with 5 mM p-nitrophenyl phosphate in the dark. Optical density (OD)
was read at 405 nm by using the EL 311 SX microplate autoreader (BioTek Instruments, Inc., Winooski,
VT, USA). OD values were converted in nanomoles of ALP by using a standard curve previously
obtained with known ALP quantities (from 4 to 20 nanomoles). The protein content of each sample
was analyzed with a BCA kit. Finally, results were expressed as nM ALP/µg protein.
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2.7. Statistical Analysis
Statistical analysis has been performed for all experiments and is detailed in each figure caption.
3. Results
3.1. Synthesis and Physicochemical Characterization of Silver Nanowires
AgNWs were successfully synthesized using the polyol method. During the synthesis, as the
temperature was increased, a typical change in color from clear to yellow, then orange, red, grey and
green was observed (Figure 1A). This correlated to the changes in the UV-Vis spectrum with increasing
temperatures (Figure 1B). Below 180 ◦C a peak was present at 410 nm, this is due to the surface plasmon
resonance (SPR) signal of Ag nanoparticles and nanorods that initially form as nucleation sites for the
growth of nanowires. As the temperature increases, peaks appear at 350 nm and 380 nm, these are
attributed to the formation of Ag nanowires, as confirmed by SEM and TEM (Figure 1C,D) [25].
The XRD pattern (Figure 1E) confirmed the formation of face-centered cubic metallic Ag. In fact,
the d-values perfectly matched to PDF Number 04-0783 (Silver-3C, syn); also the intensity of the peaks
corresponded, except for (111). In the card 04-0783, the (111)/(200) intensity ratio is 2.5, whereas in our
pattern it was 3.4 indicating the formation of well-elongated AgNWs [26,27]. A minimal trace impurity
of AgCl (PDF No. 31-1238, Chlorargyrite) can be seen at 2θ 32.2◦ and 46.2◦ (Figure 1E), an aspect
sometimes reported in the synthesis of AgNWs [28]. Thus, our AgNWs synthesis product was mainly
composed of metallic silver, even though small traces of ionic silver were found, indicating that both
the synthesis and the washing steps were efficient enough to guarantee a nearly pure product. We also
studied the morphology of AgNWs obtained at the end of the synthesis. They had an average length
of 5.03 ± 1.85 µm and an average diameter of 99.45 ± 20.20 nm (See Supplementary Figure S1 online),
as determined by analyzing SEM images with ImageJ. These dimensions are in good agreement with
those reported by Yang et al. [21]. The zeta potential of AgNWs in deionized water was found to be
−10.88 ± 1.86 mV, indicating their tendency to aggregate in aqueous media.
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3.2. Characterization of Composite Gels
AgNWs were used to formulate composite chitosan gels; the thermosensitive gels were composed
of chitosan crosslinked with glycerol phosphate and mixed with a chitosan/hydroxyapatite composite
(HACS). As previously described, full physicochemical characterization can be found in [17,18] and
SEM images are available in the supplementary information (Figure S2). A significant reduction in
the time of sol/gel transition was observed on the addition of the HACS composite to the chitosan
gel (from 12.0 ± 3.3 min to 3.2 ± 0.4 min; p < 0.0001; Figure 2A), no further significant change was
observed on the addition of AgNWs. When only AgNWs were added, a non-significant (p > 0.05)
reduction to 10.3 ± 2.4 min was observed (see Supplementary Figure S3 online). On the other hand,
AgNWs induced a further significant increase in gel strength (to 0.138 ± 0.005 N, p < 0.01) after the
increase initially observed on addition of HACS (from 0.035 ± 0.001 N to 0.089 ± 0.024 N, p < 0.01;
Figure 2B). Also, AgNWs alone were able to significantly increase the strength of the chitosan gel
(to 0.136 ± 0.001 N, p < 0.0001, see Supplementary Figure S4 online).
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formulations returned p < 0.01 before and p < 0.0001 after gelation. Post-hoc Tukey’s test results 
showed that before gelation only CS is different from all other gels (# p < 0.05), while the individual 
results for after gelation are reported on the graph (** p < 0.01; **** p < 0.0001). 
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The addition of HACS significantly increased the total amount of water absorbed at equilibrium from 
47.5% ± 8.4% to 93.5% ± 34.7% (p < 0.05, Figure 3A), likely causes for this could be the significant 
increase in porosity from 14.5% ± 3.6% to 26.3% ± 1.9% (p = 0.01, Figure 3B), the higher 
interconnectivity within the scaffold and the higher number of available hydrophilic groups or a 
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Degradation studies have been performed to understand what factors affect the degradation of 
the composite hydrogels (see Supplementary Figure S5 online). In the degradation experiment, 
control hydrogels were incubated in PBS for three weeks and an initial weight loss was observed at 
seven days. This was then maintained (p > 0.05) for the duration of the three weeks, indicating that 
an initial weight loss due to the solubilization of lightly crosslinked chains is likely to happen in the 
first week after implantation, however in absence of enzymes, this degradation does not proceed 
(Figure 3C). A smaller weight loss was observed for CS-HACS (p > 0.05) and CS-HACS-AgNWs (p < 
0.01) at seven days, confirming that enhanced crosslinking is present in these composites. An 
unchanged residual weight was recorded also for these two composites at two and three weeks. 
When lysozyme was added, CS gels showed significantly increased degradation during the three 
weeks with a final total weight loss of 91.7 ± 7.1%. A similar pattern was observed also for the 
composite gels, for a significant weight loss was observed after three weeks. At all time points, the 
weight loss of CS-HACS-AgNWs was significantly lower (p < 0.01) than both CS and CS-HACS gels. 
Biomineralization of hydrogels was studied soaking them in SBF for three weeks to evaluate surface 
Ca/P deposition by SEM-EDS. A significant increase in Ca/P deposit was observed after three weeks 
of incubation of hydrogels in simulated body fluid (SBF), this was particularly true for CS-HACS 
hydrogels (Figures 3D and 4). This was expected as the already present hydroxyapatite can function 
as a nucleation site for the deposition of calcium salts [18]. On the other hand, the absence of 
hydroxyapatite in CS gels led to a non-significant deposition of salts (p > 0.05). 
Figure 2. Physical characterization of the hydrogels: it ( , l ), c itosan gel with chitosan
hydroxyapati e composite (CS-HACS, lig t gre ) i l i it san ydroxyapatite
composite and silver nanowires (CS-HACS- g , l tion ti e calculated by the
inverted tube method. Data re repo ted as mean± SD (n = 9). One-way Analysis of Var ance (ANOVA)
returned p < 0.0001. Post-hoc Tukey’s comparison test re ults are shown in t e graph: **** indicates
p < 0.0001 as compared to the control (CS); (B) Gel strength calculated by texture analysis before (empty
bars) and after (filled bars) g lation. Data are represented as mean ± SD (n = 3). The t-test performed
on all samples before and after gelation showed s g ificantly different strength valu s for all g ls
($$ indicat s p < 0.01 nd $$$$ p < 0.0001). One-way ANOVA to compare the different formulations
retu ned p < 0.01 before and p < 0.0001 after gelation. Post-hoc Tukey’s test results showed that before
gelation only CS is different from all other gels (# p < 0.05), whil th individual results for after gelation
are reported on the graph (** p < 0.01; **** p < 0.0001).
Equilibrium swelling provides an idea of t t of ater a hydrogel can absorb.
The ad it on of si nificantly increased the tot l amount of w ter absorb d at eq ilib ium
from 47.5% ± 8.4% to 93.5% ± 34.7% (p < 0.05, Figur 3A), likely causes for this could be the
sig ificant i crease in porosity from 14.5% ± 3.6% to 26.3% ± 1.9% (p = 0.01, Figure 3B), the higher
intercon ectivity within the scaffold and the hi er er f a aila le ydrophilic groups or a
combination of them.
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Figure 3. Further physical characterization, enzymatic degradation and bioactivity determination of
hydrogels: CS (black), CS-HACS (light grey) and CS-HACS-AgN s (dark grey). (A) Equilibrium
swelling (Q%), data are reported as mean ± SD (n = 6). One-way ANOVA returned p < 0.05, results
of the post-hoc Tukey’s multi-comparison test are reported in the graph (* p < 0.05); (B) Gels porosity
determined by gravimetric method, data are reported as mean± SD (n = 3). One-way ANOVA returned
p < 0.05, results of the post-hoc Tukey’s multi-co parison test are reported in the graph, (* p < 0.05
and ** p < 0.01); (C) Gels degradation in the presence of lysozyme (full bars), the empty bars represent
the relative control gels treated in PBS; data are reported as mean ± SD (n = 3). One-way ANOVA
returned p < 0.05, results of the post- oc Tukey’s multi-comparison test are reported in the graph
(# p < 0.05). A t-test was performed against the PBS incubated s mples for each gel at ach time point;
* < 0.05, ** p < 0.01 and *** p < 0.01; (D) Percentage surface al ification of hydrogels incubated at
37◦C in SBF for 7, 14 and 21 days as calculated by image a l i i eJ and BoneJ from SEM
images. Controls were only incubate f i eionized water. Results are reported as mean
± S (n l l it the sy bol # resulted to be sign ficantly different from their control
sample (p < 0.05). One- . ly hen testing CS-HACS at differen time
points, the results of the post-hoc uke ’s test are reported in the graph (* p < .05,
** p < 0.01).
Degradation studies have been performed to understand what factors affect the degradation of
the composite hydrogels (see Supplementary Figure S5 online). In the degradation experiment, control
hydr gels were incubated in PBS for three weeks and an initial weight loss was observed at seven
days. This was then maintained (p > 0.05) f r the durati n of the three week , i di ting t at an initial
weight loss due to the solubilizati of l ghtly crosslinked chains is likely to happen in th first week
after implantation, however in absence of enzy es, this degradation does not proceed (Figure 3C).
A smaller weight loss was obs rved for CS-HACS (p > 0.05) and CS-HACS-AgNWs (p < 0.01) at seven
days, confirming that enhanced crosslinking is present in these composites. An unchanged residual
weight was recorded also for these two composites at two and three weeks. When lysozyme was
added, CS gels showed significantly increased degradation during the three weeks with a final total
weight loss of 91.7 ± 7.1%. A similar pattern was observed also for the composite gels, for a significant
weight loss was observed after three weeks. At all time points, the weight loss of CS-HACS-AgNWs
was significantly lower (p < 0.01) than both CS and CS-HACS gels. Biomineralization of hydrogels
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was studied soaking them in SBF for three weeks to evaluate surface Ca/P deposition by SEM-EDS.
A significant increase in Ca/P deposit was observed after three weeks of incubation of hydrogels
in simulated body fluid (SBF), this was particularly true for CS-HACS hydrogels (Figures 3D and
4). This was expected as the already present hydroxyapatite can function as a nucleation site for the
deposition of calcium salts [18]. On the other hand, the absence of hydroxyapatite in CS gels led to a
non-significant deposition of salts (p > 0.05).
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Figure 4. Energy-dispersive X-rays spectroscopy (EDS) coupled SEM images (1000× magnification)
of CS, CS-HACS and CS-HACS-AgNWs hydrogels incubated in SBF for 7, 14 and 21 days. Control
samples were incubated in water for 5 h. Images show an overlay of SEM pictures with EDS data:
Ca (green), P (red) and co-localisation of Ca/P (yellow).
For further investigation of salt deposition within the scaffold, dry scaffolds were scanned by
micro-CT with low X-ray en rgy and low pplied voltage (40 kV). As reported by Cancian et al.,
the region of inte st (ROIs) characterized by a higher density may be attributed to salts, such as
Ca-P [18]. As expected, quantitat ve analys s of the hydrogels highlighted a sign ficantly higher salt
deposit on within the scaffolds containing HACS in comparison to samples not incubated in PBS.
Moreover, n increase in salt depositi n by time was noticed for both CS-HACS and CS-HACS-AgNWs
hydrogels (Supplementary Figures S6 and S7 online).
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3.3. Ag+ Release
AAS was used to determine the total Ag+ released from AgNWs and CS-HACS-AgNWs scaffolds.
Silver release was studied over a period of 38 days, using ultrapure water as medium. Both
materials showed silver release in water (Figure 5), with a faster release at the beginning and a
slow sustained release over time. After 38 days, approximately 11 ppm of Ag+ were released from
AgNWs, while nearly 1 ppm was released from the hydrogels.Pharmaceutics 2019, 11, x 11 of 19 
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3.4. Antimicrobial Activity of AgNWs
The antimicrobial activity of AgNWs was tested against four bacterial strains. Three are
gram-positive (Staphylococcus aureus, Staphylococcus saprophyticus and Methicillin-resistant
Staphylococcus aureus) while Escherichia coli is gram-negative. Staphylococci comprise nearly
two-thirds of all pathogens implicated in orthopedic implant infections and thus are clinically relevant
in testing materials developed for bone regeneration [19]. Antibacterial efficacy was also assessed
against E. coli as it often serves as a gram-negative bacterial representative and allowed us to estimate
the broadness of the potential antibacterial spectrum. We monitored bacterial growth in liquid culture
medium in the presence of increasing concentrations of AgNWs (Figure 6) and determined the lag time
before exponential growth (the period when the bacteria are adjusting to the nascent environment),
the time required by the bacterial populations to reach stationary phase (when the OD600nm stabilizes
due to the rate of cell death equaling the rate of cell division) and the maximum optical density
(OD600nm) reached at stationary phase (see Supplementary Figure S8 online). S. aureus growth was
completely inhibited by 100 µg/mL AgNWs (see Supplementary Figure S7 online). The lag phase
was found to be statistically increased for the concentration 50 µg/mL (p < 0.01) in comparison to the
untreated culture. Meanwhile, the time to reach the stationary phase and the maximum OD600nm were
not statistically different from the untreated culture (see Supplementary Figure S7 online). For E. coli
the lag phase was prolonged (compared to the untreated culture) for all the studied concentrations
(p < 0.001 for 12.5 and 25 µg/mL and p < 0.0001 for both 50 and 100 µg/mL; see Supplementary Figure
S8 online), with a fourfold increase at 100 µg/mL. MRSA did not show sensitivity to AgNWs at the
tested concentrations, while S. saprophyticus demonstrated the highest susceptibility, with no growth at
all observed when AgNWs were employed at concentrations equal or above 50 µg/mL.
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3.5. Antibacterial Activity of the Composite Scaffolds
One of the main objectives of this study was to develop scaffolds imparting antibacterial
activity through silver nanowires incorporation and thus we tested the antibacterial activity of
CS-HACS-AgNWs hydrogels against CS-HACS scaffolds towards S. aureus, E. coli, MRSA and
S. saprophyticus. The analyses were performed incubating the bacterial suspensions with the sterile
dried composites. Biofilm formation on CS-HACS and CS-HACS-AgNWs hydrogels was investigated
after 24 h, staining the fixed hydrogels to highlight the presence of bacteria. Both of the scaffolds
were found to suppress biofilm formation on the scaffolds, as no bacteria have been imaged on
the considered surfaces. Hence, both chitosan and silver nanowires appeared to prevent biofilm
formation within the considered period of time (see Supplementary Figure S9 online). The antibacterial
activity of the composites was studied also in suspension. As reported in Figure 7, CS-HACS-AgNWs
scaffolds showed a remarkable bactericidal activity against all the four bacteria strains, giving a growth
inhibition of 100% ± 9.6 × 10−6 (p < 0.001) against E. coli, 100% ± 9.2 × 10−7 (p < 0.000001) against S.
aureus, 99.99% ± 0.0065 (p < 0.05) against MRSA and of 100% ± 0 (p < 0.000001) against S. saprophyticus,
at 24 h. On the other hand, CS-HACS scaffolds did not show the ability to stop the bacterial growth
within 24 h, except for S. saprophyticus. Overall these results highlighted that the addition of AgNWs
was essential in imparting bactericidal activity to hydrogels, and that chitosan and AgNWs might be
acting synergistically.
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****p<0.0001) while # represents the statistical difference between CS-HACS and CS-HACS-AgNWs 
scaffolds (#p<0.05, ##p<0.01; ###p<0.001 and ####p<0.0001). 
3.6. Proliferation and Differentiation of MC3T3-E1 
The biocompatibility of the hydrogels was verified by determining the growth of MC3T3-E1 cells 
through the adenosine triphosphate (ATP) assay, a well-known reproducible and reliable assay of 
cell viability (Figure 8A) [29]. The cells responded well to all the hydrogels with an increase in cell 
number, although they did not proliferate as well as the cells seeded on tissue culture polystyrene 
plates, taken as control cultures. A significant enhancement of cell growth was detected in HACS 
containing hydrogels, as shown by the increase in cell number at both days 7 and 14. Although the 
HACS did not allow the cells to proliferate as well as in the control, it supported cell growth better 
than the hydrogels containing CS only. At 14 days, no significant difference between the CS-HACS 
and the CS-HACS-AgNWs was detected. Furthermore, the differentiation of the pre-osteoblast 
MC3T3-E1 cells was determined in order to evaluate the potential of the hydrogels to support 
osteoblast differentiation for bone repair. The alkaline phosphatase (ALP) assay was performed as 
ALP activity is considered to be an early biochemical marker for osteoblast differentiation and an 
indicator of bone tissue formation [30]. The MC3T3-E1 cells began to differentiate into osteoblasts in 
all the samples, as confirmed by the presence of ALP activity after seven days in culture (Figure 8B). 
ALP activity was higher in the control and CS samples than in the other hydrogels. The statistical 
Figure 7. Growth of S. aureus, E. coli, MRSA and S. saprophyticus in suspensions containing CS-HACS
(light grey), CS-HACS-AgNWs (dark grey) and LB only (black). Results are reported as mean ± SD.
One-way ANOVA was performed between different samples, when significant a Tukey’s post-hoc
multicomparison test was performed, results are reported on the graph. * represents the statistical
difference between scaffolds and bacterial suspensions (* p < 0.05, ** p < 0.01; *** p < 0.001 and
**** p < 0.0001) while # represents the statistical difference between CS-HACS and CS-HACS-AgNWs
scaffolds (# p < 0.05, ## p < 0.01; ### p < 0.001 and #### p < 0.0001).
3.6. Proliferation and Differentiation of MC3T3-E1
The biocompatibility of the hydrogels was verified by determining the growth of MC3T3-E1 cells
through the adenosine triphosphate (ATP) assay, a well-known reproducible and reliable assay of cell
viability (Figure 8A) [29]. The cells responded well to all the hydrogels with an increase in cell number,
although they did not proliferate as well as the cells seeded on tissue culture polystyrene plates, taken as
control cultures. A significant enhancement of cell growth was detected in HACS containing hydrogels,
as shown by the increase in cell number at both days 7 and 14. Although the HACS did not allow the
cells to proliferate as well as in the control, it supported cell growth better than the hydrogels containing
CS only. At 14 days, no significant difference between the CS-HACS and the CS-HACS-AgNWs was
detected. Furthermore, the differentiation of the pre-osteoblast MC3T3-E1 cells was determined in
order to evaluate the potential of the hydrogels to support osteoblast differentiation for bone repair.
The alkaline phosphatase (ALP) assay was performed as ALP activity is considered to be an early
biochemical marker for osteoblast differentiation and an indicator of bone tissue formation [30].
The MC3T3-E1 cells began to differentiate into osteoblasts in all the samples, as confirmed by the
Pharmaceutics 2019, 11, 116 14 of 19
presence of ALP activity after seven days in culture (Figure 8B). ALP activity was higher in the
control and CS samples than in the other hydrogels. The statistical analysis revealed that there was
no statistical difference between the control and CS samples at seven days. With the addition of the
hydroxyapatite a decrease in ALP was observed at day 7 while after 14 days no difference between CS
and CS-HACS gels was detected. At day 14, a decrease in enzyme activity was visible in all cultures;
this is expected as the highest concentration of ALP is expressed during the early stages of bone
formation [31].
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improved by the addition of AgNWs, as a consequence of their metallic nature—which provides high 
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al. showed that the smaller the diameter the stronger AgNWs are; the AgNWs used in this study, 
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4. Discussion
Bone fractures are often exacerbated by the occurrence of bacterial infections that can lead to
prolonged or even absent bone healing. Therefore, 3D-engineered scaffolds with both bioactive
and infection control capabilities are urgently needed. In this study, we aimed to develop
the first biodegra able and bioactive injectable hydrogel enriched with AgNWs with intrinsic
antibacterial properti s. Injectable hydrogels are potentially ideal pharmaceutical f rmulations for
bone regeneration as th y reduc the discomf rt of the patient due to their non-invasive administration.
However, a relatively fast gelation time, once administrated, is es ential for this type of ormulation as
thi allows an effective entrapment of additives or cells at the site of application. CS-GP hydrogels are
known f r being thermosensitiv as th y und rgo soluti n-gel transition i a temper ture-d pend nt
manner [32]. Our in vitro studies demonstrated that addition of HACS significantly diminished
gelation time at body temperature, in comparison to CS only gels, wherea AgNWs did not affect
this property. This behavior may be attributed to the higher number of functi nal groups available
for ionic interactions in CS-HACS than in CS hydrogels. Even though chitosan-based hydrogels are
ideal scaffolds for tissue regeneration as they mimic the extracellular matrix, they present inadequate
mechanical performance, which makes them too weak for applications in the musculoskeletal system.
Multiple approaches have been taken by researchers to overcome this problem, like incorporating
nanoparticles [16]. In this study, the addition of HACS significantly enhanced the compressive gel
strength in comparison to the chitosan only gel. This result was further improved by the addition
of AgNWs, as a consequence of their metallic nature—which provides high strength—and the
one-dimensional morphology that defines the mechanical behavior. In fact, Cao et al. showed
that the smaller the diameter the stronger AgNWs are; the AgNWs used in this study, with a diameter
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around 99 nm, present a behavior between brittle and ductile [33]. A further important property
of a hydrogel for tissue regeneration is its swelling capacity: swelling is related to water uptake
from the surrounding tissues that favors nutrient and cell migration [34,35]. Chitosan is known
for its hydrophilic nature due to the presence of several hydroxyl and amino groups able to form
hydrogen bonding with the surrounding water. The inclusion of HACS into CS-based hydrogels
ensured a higher water uptake, due to the higher number of hydrophilic groups but also to the
higher porosity of these gels in comparison to the CS only gels. Thus, HACS is not only acting as a
crosslinker, as shown by the enhanced mechanical behavior, but also as a spacer between polymeric
chains enhancing the porosity and hydrophilicity of the composites. During bone repair, the aim is
to employ materials that will be resorbed while the new bone is forming and will allow drug release.
Thus, degradation studies have been performed to understand what factors affect the resorption
of the composite hydrogels. The in vitro degradation studies were carried out in the presence of
lysozyme, an enzyme that degrades chitosan in vivo. Based on gravimetric analysis and observation
by SEM, CS-HACS-AgNWs hydrogels showed significantly reduced degradation in comparison to the
chitosan only gel. The addition of HACS composites had no effect on the degradation in comparison to
chitosan hydrogels, in good agreement with the findings reported by Dhivya et al. [36]. This suggests
that the introduction of AgNWs might be used to regulate and delay the degradation of the gels.
A further important step for bone regeneration is mineralization of the tissue. The in vitro apatite
formation ability of a scaffold can be correlated to its in vivo bone-bonding ability and capacity to
absorb calcium and phosphate ions from the surrounding body fluids. Indeed, Ca and P are used
by the human body to form hydroxyapatite, the bone mineral that constitutes nearly the 65% of
bone weight. Thus, the presence of hydroxyapatite on the surface of the scaffolds is essential to
promote the nucleation and growth of calcium phosphate. Our in vitro study showed that more
Ca/P deposits increased over time on the surface of the hydrogels if hydroxyapatite was present in
the composite. The data presented support the key role played by hydroxyapatite in the bioactivity
of the composite hydrogels and at the same time demonstrate that the addition of AgNWs further
supports the bioactivity. As observed previously for carbon nanotubes, AgNWs also seem to favor a
homogeneous salt deposition [18]. As mentioned, bacterial infections are a burden after bone fracture
surgeries. The controlled release of silver cation is a key factor for preventing and treating infections.
Indeed, Ag+ can interact with electron donor groups in biological molecules containing sulphur,
oxygen or nitrogen, causing damage to the microorganisms [2]. Silver is present in AgNWs in the
metallic state, this has no antibacterial properties, however it is able to react with moisture and O2
in the culture medium, producing ionized Ag+. This is highly reactive as it directly interacts with
proteins and promotes structural changes in the bacterial cell wall, leading to cell distortion and death.
As reported by Kumar et al., the steady and prolonged release of silver from scaffolds at a minimum
concentration level of 0.1 part per billion (ppb) can provide effective antimicrobial activity [37]. In our
study we have explored the antibacterial activity of AgNWs and CS-HACS-AgNWs. The cumulative
release profiles of silver cations from AgNWs and hydrogels indicate that the total silver ion released
is well within the potential toxic limit mentioned for human cells which is 10 ppm (µg/mL), but high
enough to have the potential to inhibit bacterial growth. The antibacterial properties of AgNWs
against suspension cultures of E. coli, S. aureus, MRSA and S. saprophyticus were evaluated. AgNWs
were able to prevent the growth of S. aureus and S. saprophyticus at concentrations higher than 50
µg/mL, they affected the lag phase of S. aureus at concentrations higher than 50 µg/mL and of E. coli
for all the studied concentrations. Moreover, the OD600 of E. coli stationary phase was statistically
different for the concentration 50 µg/mL. Our results are in good agreement with Cui and Liu [38]:
they carried out a similar experiment for E. coli showing that AgNWs were able to affect the lag
phase for concentrations equal or higher than 12.5 µg/mL. However, in their work, concentrations
of AgNWs equal to 50 µg/mL were able to prevent bacterial growth. In agreement with our study,
Hong et al. reported a 6 h delay of E. coli growth for the AgNWs concentration 50 µg/mL, without any
inhibition [39]. Finally, in our work, E. coli was found to exhibit greater sensitivity to AgNWs than S.
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aureus; this trend has been reported for silver nanoparticles too [40]. Unfortunately, no activity was
observed against MRSA. The antimicrobial properties of the composite hydrogels were evaluated both
in suspension and on the scaffold. On one hand, chitosan is known to exhibit antimicrobial properties
against fungi, yeasts, viruses and bacteria, including E. coli and S. aureus, inhibiting DNA transcription
and mRNA synthesis [41]. On the other, the introduction of AgNWs was expected to enhance these
antibacterial properties due to the release of Ag+ from the scaffolds. Indeed, CS-HACS-AgNWs could
reduce the bacterial growth of over 99% for all the studied species over a period of 24 h in suspension,
in comparison to CS-HACS hydrogels. Moreover, biofilm formation was prevented on the hydrogels
with or without AgNWs, over a period of 24 h. The ability of CS-HACS hydrogels to inhibit bacterial
growth on the scaffold, may be explained by the direct interaction of positively charged chitosan with
negatively charged bacterial cell surface, which caused cell membrane disruption leading to death [42].
These results are in good agreement with previous literature studies, regarding the ability of low
viscosity chitosan to prevent Staphylococcus and E. coli growth [43,44]. The most interesting results
were obtained when the scaffolds were tested against MRSA. AgNWs alone were not able to exert any
effect on MRSA at concentrations as high as 100 µg/mL, but a very high activity was observed when
the nanowires were included in the scaffold, even though the release studies suggested that in this case
bacteria will be subjected to much lower concentrations of silver ions. The combination of chitosan
and AgNWs acted in a synergistic manner, with chitosan increasing the bacterial cell wall permeability
and allowing an easier access of Ag+ into the cell [45]. A further important property of a scaffold
for bone tissue engineering is osteogenicity. Researchers define as osteogenic a scaffold that favors
the adhesion and proliferation of osteoprogenitor cells, therefore the proliferation of pre-osteoblasts
(MC3T3-E1) was studied. Cell number significantly increased on CS-HACS and CS-HACS-AgNWs
more than in gels with CS only over a period of 14 days. This indicates a good biocompatibility of
the studied biomaterials. Cell differentiation into osteoblasts was investigated by ALP assay that is a
marker of the early stages of osteogenic differentiation. ALP plays a role in the conversion of inorganic
pyrophosphate into inorganic phosphate, a process that promotes the mineralization of the deposited
bone matrix [46]. Over a period of 14 days, all the studied hydrogels promoted cell differentiation
at the same level. However, there was a decrease for all the studied cultures between 7 and 14 days.
ALP decrease by time might be explained due to the cells entering a new development stage and
not because the hydrogels are unable to sustain osteogenic differentiation, however this should be
further investigated. Further investigations are also required to understand the effect of AgNWs on the
production and detection of ALP at 7 days. It is known that silver has a high affinity for thiol groups,
it is therefore possible to postulate the formation of a complex between silver and ALP that might be
responsible for the modulation of the enzyme activity as seen in vivo by Adeyemi and Adewumi [47].
5. Conclusions
The addition of silver nanowires into the chitosan-hydroxyapatite hydrogel scaffolds did not
interfere with the rapid sol/gel transition at body temperature, enhancing both the mechanical and the
bioactive properties of the materials. The presence of AgNWs induced a reduction in the degradation
rate of the hydrogels, suggesting that composites with a tailored degradation pattern can be designed
in this manner. The presence of chitosan in the scaffolds allowed for a slow controlled release of
Ag+ and provided a synergistic effect towards antibacterial activity, manifested also against resistant
bacterial strains such as MRSA. Furthermore, the gels proved to be biocompatible and bioactive,
allowing in vitro cell proliferation. The results obtained warrant further investigations into clinical
application, as the formulation is injectable and has proven bioactive, antimicrobial and biocompatible
properties. Further, it can be used as a controlled delivery platform not only for Ag+ but potentially
for other therapeutic molecules.
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Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4923/11/3/116/s1,
Figure S1. AgNWs size distribution obtained by SEM image analysis. (A) Length (mean 5.03 ± 1.85 µm; n = 28)
and (B) diameter (mean 99.45 ± 20.20 nm, n = 28). Shapiro-Wilk normality test returned p > 0.05 for both
length and diameter, Figure S2. SEM images of HACS (top) and FTIR spectra of the three hydrogels (bottom).
Figure S3. Physical characterisation of the hydrogels: CS (black), CS-HACS-AgNWs (black background with
dark grey lines), CS-HACS (light grey) and CS-HACS-AgNWs (dark grey). Gelation time calculated by the
inverted tube method. Data are reported as mean ± SD (n = 9). One-way ANOVA returned p < 0.0001. Post-hoc
Tukey’s comparison test results are shown in the graph: **** indicates p < 0.0001 and ** indicates p < 0.001.,
Figure S4. Gel strength calculated by texture analysis before (empty bars) and after (filled bars) gelation. Data
are represented as mean ± SD (n = 3). The t-test performed on all samples before and after gelation showed
significantly different strength values for all gels ($$ indicates p < 0.01 and $$$$ p < 0.0001). One-way ANOVA
to compare the different formulations returned p < 0.01 before and p < 0.0001 after gelation. Post-hoc Tukey’s
test results showed that before gelation only CS is different from all other gels (# p < 0.05), while the individual
results for after gelation are reported on the graph (** p < 0.01; **** p < 0.0001)., Figure S5. SEM images (200×
magnification) of the degradation process in PBS and in lysozyme for CS, CS-HACS and CS-HACS-AgNWs gels
at 7, 14 and 21 days., Figure S6. MicroCT images of CS, CS-HACS and CS-HACS-AgNWs hydrogels incubated
in SBF for 7, 14 and 21 days. The arrow indicates an area of mineralized tissue characterized by a higher X-ray
absorption than the surrounding hydrogel., Figure S7. Average % salt deposition on different types of hydrogel
samples (from microCT). Data are reported as mean ± SD (n = 3). One-way ANOVA returned p < 0.05 for both
gels containing AgNWs, compared to control, and p < 0.001 was obtained for CS-HACS hydrogels both at 14 and
21 days compared to the control. A Tukey’s post-hoc multicomparison test was performed, results are reported on
the graph. The symbol* indicates statistical difference when comparing the two gels containing HACS at each
time point. The symbol # indicates statistical difference of a gel in comparison to the chitosan control at a set
time point. The symbol $ is used for specific comparisons as indicated in the graph., Figure S8. Bacterial growth
lag time, time to reach the stationary phase, and O.D. at stationary phase for different bacteria in suspension
treated with 0 (grey), 12.5 (green), 25 (blue), 50 (red) and 100 (black) µg/mL of AgNWs. Data are reported as
mean ± S.D. (n = 3). One-way ANOVA was performed between different AgNWs concentrations against the
same bacteria, when significant a Tukey’s post-hoc multicomparison test was performed, results are reported
on the graph. The symbol* indicates statistical difference when compared to 0 µg/mL, the symbol # indicates
comparison with 100 µg/mL, the symbol $ is used for specific comparisons as indicated in the graph., Figure S9.
Microscopy images of biofilm formation on CS-HACS, CS-HACS-AgNWs hydrogels and controls after fuchsin (E.
coli) or crystal violet (S. aureus, MRSA and S. saprophyticus) staining. Magnification 100×.
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